CD44 and glioblastoma: Comparing GBM cell lines LN18 and D270, we observed that LN18 exhibited low pMAPK, high CD44 expression and sensitivity to Fsk–IBMX treatment, whereas D270 showed the opposite characteristics, consistent with the other GBM cell lines analyzed herein (Supplementary Figure S4).